Ocular Tuberculosis in Pediatrics: A Case Report
Keywords:Adolescent, Tuberculosis, Ocular/diagnosis, Uveitis/diagnosis
A 17-year-old male was taken to the emergency department for decreased left visual acuity and floaters beginning that same day. There was a history of exposure to pulmonary tuberculosis five years before (mother as index case) followed by a four-month period of isoniazid prophylaxis. The ophthalmic examination showed posterior and intermediate uveitis in the left eye. Laboratory tests were normal; IgG for herpes simplex 1 was positive and both the varicella-zoster virus and remaining serologic tests were negative. Chest radiography was normal. Two weeks later, an epiretinal membrane with risk of tractional retinal detachment was observed. The Mantoux tuberculin skin test showed an induration of 15 mm and the IGRA test was positive. Sputum and vitreous humor samples were collected. Quadruple therapy and prednisolone were started. Ten days later, a posterior vitreous detachment with underlying vitreous hematoma was observed. Posterior vitrectomy and peripheral endolaser were performed without complications. One month later, the microbiological results became available, with the identification of Mycobacterium tuberculosis. Corticosteroids were weaned progressively. Antituberculous drugs were maintained for six months. The patient made a full recovery.
Teixeira-Lopes F, Alfarroba S, Dinis A, Gomes MC, Tavares A. Ocular tuberculosis – a closer look to an increasing reality. Pulmonology. 2018;24:289-93. DOI: https://doi.org/10.1016/j.pulmoe.2018.02.006
Haq A, Shaheen F, Farooq S. Various spectrum of ocular tuberculosis. J Ayub Med Coll Abbottabad. 2021;33:332-4.
Figueira L, Fonseca S, Ladeira I, Duarte R. Ocular tuberculosis: position paper on diagnosis and treatment management. Rev Port Pneumol. 2017;23:31-8. DOI: https://doi.org/10.1016/j.rppnen.2016.10.004
Marin-Acevedo JA, Chirila RM, Cowart JB. Ocular tuberculosis. J Gen Intern Med. 2019;34:2288-9. DOI: https://doi.org/10.1007/s11606-019-05129-w
Testi I, Agrawal R, Mehta S, Basu S, Nguyen Q, Pavesio C, et al. Ocular tuberculosis: where are we today? Indian J Ophthalmol. 2020;68:1808-17. DOI: https://doi.org/10.4103/ijo.IJO_1451_20
Shakarchi FI. Ocular tuberculosis: current perspectives. Clin Ophthalmol. 2015;9:2223-7. DOI: https://doi.org/10.2147/OPTH.S65254
Hamade IH, Tabbara KF. Complications of presumed ocular tuberculosis. Acta Ophthalmol. 2010;88:905-9. DOI: https://doi.org/10.1111/j.1755-3768.2009.01579.x
Gunasekeran DV, Gupta B, Cardoso J, Pavesio CE, Agrawal R. Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population. 2017;26:865-9. DOI: https://doi.org/10.1080/09273948.2017.1296580
Rosenbaum JT. Uveitis: etiology, clinical manifestations, and diagnosis. UpToDate. [consultado 2021 dez 15]. Disponível em: https://www.uptodate.com/contents/uveitis-etiology-clinical-manifestations-and-diagnosis?search=uveitis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H3.
Shukla D, Kalliath J, Dhawan A. Tubercular retinal vasculitis: diagnostic dilemma and management strategies. Clin Ophthalmol. 2021;15:4681. DOI: https://doi.org/10.2147/OPTH.S284613
Adams LV, Starke JR. Tuberculosis disease in children. UpToDate. [consultado 2022 dez 10]. Disponível em: https://www.uptodate.com/contents/tuberculosis-disease-in-children?search=tuberculosis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H10.
Neuhouser AJ, Sallam A. Ocular tuberculosis. StatPearls. Treasure Island: Stat Pearls Publishing; 2022.
Bigdon E, Steinhorst NA, Weissleder S, Durchkiv V, Stübiger N. Treatment in latent tuberculosis uveitis - is immunosuppression effective or is conventional 3- or 4-drug antituberculosis therapy mandatory? J Clin Med. 2022;11:2419. DOI: https://doi.org/10.3390/jcm11092419
How to Cite
Copyright (c) 2023 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.